drugset / Trial / NCT00675116
GW823296 Repeat Dose Study In Healthy Male And Female Subjects
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a study to evaluate the safety, tolerability and pharmacokinetics of GW823296 following 28 days, once-daily repeat oral doses.
Timeline
- Start
- 2008-04
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Orvepitant | Small molecule | — | Oral |
Indications
No indication recorded.